VanEck Associates
TARO

VanEck Associates’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

VanEck Associates’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,977
Closed -$126K – 1430
2024
Q1 		$126K Buy
2,977
+133
+5% +$5.6K ﹤0.01% 1223
2023
Q4 		$119K Sell
2,844
-90
-3% -$3.32K ﹤0.01% 1219
2023
Q3 		$111K Buy
2,934
+187
+7% +$7.02K ﹤0.01% 1222
2023
Q2 		$104K Sell
2,747
-19
-0.7% -$596 ﹤0.01% 1235
2023
Q1 		$67K Sell
2,766
-39
-1% -$1.14K ﹤0.01% 1287
2022
Q4 		$81K Sell
2,805
-10
-0.4% -$297 ﹤0.01% 1281
2022
Q3 		$84K Buy
2,815
+9
+0.3% +$310 ﹤0.01% 1205
2022
Q2 		$101K Sell
2,806
-132
-4% -$5.03K ﹤0.01% 1221
2022
Q1 		$127K Buy
2,938
+16
+0.5% +$748 ﹤0.01% 1190
2021
Q4 		$146K Sell
2,922
-211
-7% -$11.8K ﹤0.01% 1172
2021
Q3 		$199K Sell
3,133
-227
-7% -$15.7K ﹤0.01% 1034
2021
Q2 		$242K Buy
3,360
+28
+0.8% +$2.06K ﹤0.01% 982
2021
Q1 		$246K Buy
+3,332
New +$253K ﹤0.01% 923
2014
Q3 		– Sell
-4,270
Closed -$599K – 735
2014
Q2 		$599K Sell
4,270
-17
-0.4% -$1.89K ﹤0.01% 463
2014
Q1 		$476K Buy
4,287
+890
+26% +$96.9K ﹤0.01% 473
2013
Q4 		$336K Buy
+3,397
New +$295K ﹤0.01% 507

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $10.6B AUM 19.99% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

VanEck Associates's TARO Position: Q2 2024 in Review

VanEck Associates sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 2,977 shares — an estimated $126K sold.

VanEck Associates first reported a position in TARO in Q4 2013 and held it in 16 quarters. The position peaked at $599K in Q2 2014. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • VanEck Associates reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • VanEck Associates sold 2,977 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $126K.
  • VanEck Associates first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 16 quarters.
  • VanEck Associates's Taro Pharmaceutical Industries Ltd. position peaked at $599K in Q2 2014.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on VanEck Associates's 13F filing for Q2 2024, filed 31 Jul 2024.